OpenVSafe by OpenVAERS
Search V-safe

N3P-26331-61750

4 vaccinations 7 coded responses 37 check-ins 5 free-text entries 0 call cases
Sex
Female
Age at first dose
0-4
ZIP prefix
080 / NJ
Registered
2022-07-27
Relationship
Child or adolescent in my care
Guardian
A6C-23014-53288
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2022-07-12
    Dose 1 — Pfizer-BioNTech
  2. 2022-07-27
    Registered in v-safe
  3. 2022-07-27
    Health check-in — day 14, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  4. 2022-08-02
    Dose 2 — Pfizer-BioNTech
  5. 2022-08-02
    Health check-in — day 0, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  6. 2022-08-03
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Fair · Fever · Sleepiness, Irritability/crying, Loss of appetite
    Under 3 check-in
  7. 2022-08-05
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  8. 2022-08-06
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  9. 2022-08-07
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  10. 2022-08-08
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  11. 2022-08-09
    Health check-in — day 7, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  12. 2022-08-16
    Survey response — day 14, dose 2, under 3
    MedDRA: Cough, Respiratory tract congestion — Feeling: Fair
    Free text: Congestion, cough
    MedDRA releases: 2024-11 · check-in free text available
  13. 2022-08-23
    Survey response — day 21, dose 2, under 3
    MedDRA: Conjunctivitis — Feeling: Good · Be unable to work or attend school
    Free text: Pink eye
    MedDRA releases: 2024-11 · check-in free text available
  14. 2022-08-30
    Health check-in — day 28, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  15. 2022-09-06
    Health check-in — day 35, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  16. 2022-10-04
    Dose 3 — Pfizer-BioNTech
  17. 2022-10-07
    Health check-in — days 1–6 daily, dose 3, under 3
    Feeling: Good · None
    Under 3 check-in
  18. 2022-10-08
    Health check-in — days 1–6 daily, dose 3, under 3
    Feeling: Good · None
    Under 3 check-in
  19. 2022-10-09
    Health check-in — days 1–6 daily, dose 3, under 3
    Feeling: Good · None
    Under 3 check-in
  20. 2022-10-10
    Survey response — days 1–6 daily, dose 3, under 3
    MedDRA: Respiratory tract congestion, Rhinorrhoea — Feeling: Fair · Sleepiness, Irritability/crying, Rash, not including the immediate area around the injection site
    Free text: Congestion and runny nose
    MedDRA releases: 2024-11 · check-in free text available
  21. 2022-10-11
    Survey response — day 7, dose 3, under 3
    MedDRA: Cough, Respiratory tract congestion, Rhinorrhoea — Feeling: Fair
    Free text: Cough, congestion, runny nose
    MedDRA releases: 2024-11 · check-in free text available
  22. 2022-10-18
    Health check-in — day 14, dose 3, under 3
    Feeling: Good
    Under 3 check-in
  23. 2022-10-25
    Health check-in — day 21, dose 3, under 3
    Feeling: Good
    Under 3 check-in
  24. 2022-11-01
    Health check-in — day 28, dose 3, under 3
    Feeling: Fair
    Under 3 check-in
  25. 2022-11-08
    Health check-in — day 35, dose 3, under 3
    Feeling: Good
    Under 3 check-in
  26. 2022-11-15
    Survey response — day 42, dose 3, under 3
    MedDRA: Cough, Oropharyngeal pain, Pyrexia, Rhinorrhoea — Feeling: Poor · Be unable to work or attend school
    Free text: Fever, cough, runny nose, sore throat
    MedDRA releases: 2024-11 · check-in free text available
  27. 2023-01-03
    Health check-in — 3 months, dose 3, under 3
    Feeling: Good
    Under 3 check-in
  28. 2023-04-04
    Survey response — 6 months, dose 3, under 3
    MedDRA: Cough, Oropharyngeal pain, Pyrexia, SARS-CoV-2 test negative, Viral infection — Feeling: Fair · Be unable to work or attend school
    MedDRA releases: 2024-11
  29. 2023-05-04
    Dose 4 — Pfizer-BioNTech
  30. 2023-05-04
    Health check-in — day 0, dose 4, under 3
    Feeling: Good · None
    Under 3 check-in
  31. 2023-05-05
    Health check-in — days 1–6 daily, dose 4, under 3
    Feeling: Fair · Fever · None
    Under 3 check-in
  32. 2023-05-06
    Health check-in — days 1–6 daily, dose 4, under 3
    Feeling: Fair · Fever · None · Be unable to work or attend school
    Under 3 check-in
  33. 2023-05-07
    Health check-in — days 1–6 daily, dose 4, under 3
    Feeling: Fair · Fever · None · Be unable to work or attend school
    Under 3 check-in
  34. 2023-05-08
    Health check-in — days 1–6 daily, dose 4, under 3
    Feeling: Good · None
    Under 3 check-in
  35. 2023-05-09
    Health check-in — days 1–6 daily, dose 4, under 3
    Feeling: Good · None
    Under 3 check-in
  36. 2023-05-10
    Health check-in — days 1–6 daily, dose 4, under 3
    Feeling: Good · None
    Under 3 check-in
  37. 2023-05-11
    Health check-in — day 7, dose 4, under 3
    Feeling: Good · None
    Under 3 check-in
  38. 2023-05-18
    Health check-in — day 14, dose 4, under 3
    Feeling: Good
    Under 3 check-in
  39. 2023-05-25
    Health check-in — day 21, dose 4, under 3
    Feeling: Good
    Under 3 check-in
  40. 2023-06-01
    Health check-in — day 28, dose 4, under 3
    Feeling: Good
    Under 3 check-in
  41. 2023-06-08
    Health check-in — day 35, dose 4, under 3
    Feeling: Good
    Under 3 check-in
  42. 2023-06-15
    Survey response — day 42, dose 4, under 3
    MedDRA: Conjunctivitis — Feeling: Fair · Be unable to work or attend school
    MedDRA releases: 2024-11

Vaccinations

DoseDateManufacturerCo-administered
12022-07-12Pfizer-BioNTech No
22022-08-02Pfizer-BioNTech No
32022-10-04Pfizer-BioNTech No
42023-05-04Pfizer-BioNTech No

Free text

Release 12 (Under 3) — day 14, dose 2, under 3

2022-08-16

Symptoms: Congestion, cough

Release 12 (Under 3) — day 21, dose 2, under 3

2022-08-23

Symptoms: Pink eye

Release 12 (Under 3) — days 1–6 daily, dose 3, under 3

2022-10-10

Systemic reaction (other): Congestion and runny nose

Release 12 (Under 3) — day 7, dose 3, under 3

2022-10-11

Systemic reaction (other): Cough, congestion, runny nose

Release 12 (Under 3) — day 42, dose 3, under 3

2022-11-15

Symptoms: Fever, cough, runny nose, sore throat

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDConjunctivitis · · ✓
SDCough · · ✓
SDOropharyngeal pain · · ✓
SDPyrexia · · ✓
SDRespiratory tract congestion · · ✓
SDRhinorrhoea · · ✓
SDSARS-CoV-2 test negative · · ✓
SDViral infection · · ✓
SROCough · · ✓
SRORespiratory tract congestion · · ✓
SRORhinorrhoea · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release